A Comparison of AI and Population PK Models to Predict the Concentrations of Antiepileptic Drugs Using Therapeutic Drug Monitoring Records
Clinical and Translational Science · 2025-10 · 18 (10)
DOI: 10.1111/cts.70353 ↗Kurz gefasst
Vergleichsstudie in der Zeitschrift Clinical and Translational Science, online erschienen am 23.10.2025. Verfasst von Tae Kyu Chung und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Applied Bioengineering, Graduate School of Convergence Science and Technology, Seoul National University, Seoul, South Korea. Hauptthemen laut MEDLINE: Anticonvulsants, Drug Monitoring, Models, Biological, Artificial Intelligence. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Population pharmacokinetic (PK) models are commonly used to predict drug concentrations, but artificial intelligence (AI) models have gained interest due to their ability to identify complex patterns without requiring mathematical assumptions. This study compares the predictive performance of AI and population PK models using therapeutic drug monitoring (TDM) records of four antiepileptic drugs (AEDs): carbamazepine (CBZ), phenobarbital (PHB), phenytoin (PHE), and valproic acid (VPA). Additionally, we analyzed key covariates influencing drug concentration predicting using the most accurate model. We extracted concentration data for CBZ, PHB, PHE, and VPA from TDM reports at Seoul National University Hospital (2010–2021), along with patient diagnoses and lab results. The predictive performances of 10 AI models, including ensemble and deep learning models, were compared with published population PK models. The predictive performance of AI models generally exceeded that of population PK models. The best‐performing AI models, such as Adaboost, eXtreme Gradient Boosting, and Random Forest, had lower root mean squared error values for CBZ, PHB, PHE, and VPA (2.71, 27.45, 4.15, and 13.68 μg/mL, respectively) compared to population PK models (3.09, 26.04, 16.12, and 25.02 μg/mL). The most influential covariate was time after last drug administration. AI models, particularly ensemble methods, showed strong predictive performance and may support individualized AED dosing, improving therapeutic outcomes while minimizing adverse effects.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Applied Bioengineering, Graduate School of Convergence Science and Technology, Seoul National University, Seoul, South Korea.
- Department of Bioengineering and Therapeutic Sciences, Schools of Pharmacy and Medicine, University of California-San Francisco, San Francisco, California, USA.
- Department of Molecular Medicine and Biopharmaceutical Sciences, Graduate School of Convergence Science and Technology, Seoul National University, Seoul, South Korea.
- Department of Clinical Pharmacology and Therapeutics, Seoul National University Hospital, Seoul, South Korea.
- Advanced Institute of Convergence Technology, Suwon, South Korea.
ORCID-Profile: Tae Kyu Chung, Howard Lee
Zitieren
APA
Chung, T. K., & Lee, H. (2025). A Comparison of AI and Population PK Models to Predict the Concentrations of Antiepileptic Drugs Using Therapeutic Drug Monitoring Records. Clinical and Translational Science, 18(10). https://doi.org/10.1111/cts.70353
Vancouver
Chung TK, Lee H. A Comparison of AI and Population PK Models to Predict the Concentrations of Antiepileptic Drugs Using Therapeutic Drug Monitoring Records. Clinical and Translational Science. 2025;18(10). doi:10.1111/cts.70353
BibTeX
@article{Chung2025,
author = {Chung, Tae Kyu and Lee, Howard},
title = {A Comparison of AI and Population PK Models to Predict the Concentrations of Antiepileptic Drugs Using Therapeutic Drug Monitoring Records},
journal = {Clinical and Translational Science},
year = {2025},
volume = {18},
number = {10},
doi = {10.1111/cts.70353}
}
EUVIMED